Cardiovascular Risk Factors from Another Point of View

Oltean, Péter Balázs; Kovács, István; Hodas, Roxana; Benedek, Theodora

doi:10.2478/jim-2021-0003

References

1. World Health Organization. Global diffusion of eHealth: making universal health coverage achievable: report of the third global survey on eHealth. World Health Organization, 2017.
Search in Google Scholar Back to article
2. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168:934-945.10.1016/j.ijcard.2012.10.046
Search in Google Scholar Back to article
3. Kannel WB, Abbott RD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018-22.10.1056/NEJM198204293061703
Search in Google Scholar Back to article
4. Kralev S, Schneider K, et al. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One. 2011;6:e24964.10.1371/journal.pone.0024964
Search in Google Scholar Back to article
5. Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.10.1007/s11883-014-0435-z
Search in Google Scholar Back to article
6. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/ American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008;118:1497-518.10.1161/CIRCULATIONAHA.107.189375
Search in Google Scholar Back to article
7. Schmermund A, Eckert J, Schmidt M, et al. Coronary computed tomography angiography: a method coming of age. Clin Res Cardiol. 2018;107:40-48.10.1007/s00392-018-1320-5
Search in Google Scholar Back to article
8. Hadamitzky M, Taubert S, Deseive S, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34:3277-3285.10.1093/eurheartj/eht293
Search in Google Scholar Back to article
9. Hadamitzky M, Achenbach S, Al-Mallah M, et al. Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry). J Am Coll Cardiol. 2013;62:468-476.10.1016/j.jacc.2013.04.064
Search in Google Scholar Back to article
10. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385:2383-2391.10.1016/S0140-6736(15)60291-4
Search in Google Scholar Back to article
11. Newby DE, Adamson PD, Berry C, et al. SCOT-HEART Investigators. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379:924-933.10.1056/NEJMoa180597130145934
Search in Google Scholar Back to article
12. Adamson PD, Williams MC, Dweck MR, et al. SCOT-HEART Investigators. Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. J Am Coll Cardiol. 2019;74:2058-2070.10.1016/j.jacc.2019.07.085689944631623764
Search in Google Scholar Back to article
13. Douglas PS, Hoffmann U, Patel MR, et al. PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372:1291-1300.10.1056/NEJMoa1415516447377325773919
Search in Google Scholar Back to article
14. Budoff MJ, Dowe D, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52:1724-1732.10.1016/j.jacc.2008.07.03119007693
Search in Google Scholar Back to article
15. Maurovich-Horvat P, Ferencik M, et al. Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol. 2014;11:390-402.10.1038/nrcardio.2014.6024755916
Search in Google Scholar Back to article
16. Miller JM, Rochitte CE, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.10.1056/NEJMoa080657619038879
Search in Google Scholar Back to article
17. Nerlekar N, Ha FJ, et al. Computed tomographic coronary angiography-derived plaque characteristics predict major adverse cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2018;10:e006973.10.1161/CIRCIMAGING.117.00697329305348
Search in Google Scholar Back to article
18. Soraya T. Inflammation in atherosclerosis. Elsevier. 2016;109(12):708-715.
Search in Google Scholar Back to article
19. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol. 2009;27:165-197.10.1146/annurev.immunol.021908.132620273440719302038
Search in Google Scholar Back to article
20. Arida A, Protogerou AD, et al. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. Int J Mol Sci. 2018;19:1890.10.3390/ijms19071890607340729954107
Search in Google Scholar Back to article
21. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care Res. 2008;59:1690-1697.10.1002/art.2409219035419
Search in Google Scholar Back to article
22. Rodean IP, Lazar L, Opincariu D, et al. Association between periodontal disease, coronary calcium score and markers of subclinical atherosclerosis in patients with unstable angina – a CT-based sub-study from the ATHERODENT clinical trial. European Heart Journal – Cardiovascular Imaging. 2020;21:jez319.299.10.1093/ehjci/jez319.299
Search in Google Scholar Back to article
23. Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol. 2007;102:662-667.10.1111/j.1572-0241.2006.01018.x17156143
Search in Google Scholar Back to article
24. Zanoli L, Signorelli SS, Inserra G, Castellino P. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology. 2017;68:463.10.1177/000331971667507627784730
Search in Google Scholar Back to article
25. Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death – a Danish nationwide cohort study. PLoS One. 2013;8:e56944.10.1371/journal.pone.0056944357407923457642
Search in Google Scholar Back to article
26. Yarur AJ, Deshpande AR, Pechman DM, et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741-747.10.1038/ajg.2011.6321386828
Search in Google Scholar Back to article
27. Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018;16:1607-1615.10.1016/j.cgh.2018.04.031615282829702298
Search in Google Scholar Back to article
28. Kirchgesner J, Beaugerie L, Carrat F for the BERENICE study group, et al. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67:1261-1268.10.1136/gutjnl-2017-31401528647686
Search in Google Scholar Back to article
29. Tsai MS, Lin CL, Chen HP, Lee PH, Sung FC, Kao CH. Long-term Risk of Acute Coronary Syndrome in Patients with Inflammatory Bowel Disease: A 13-year Nationwide Cohort Study in an Asian Population. Inflammatory Bowel Diseases. 2014;20:502-507.10.1097/01.MIB.0000441200.10454.4f24412991
Search in Google Scholar Back to article
30. Weissman S, Sinh P, Mehta TI, et al. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020;11:104-113.10.4291/wjgp.v11.i5.104740375332832194
Search in Google Scholar Back to article
31. Wang H, Liu Z, Shao J, et al. Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res. 2020;2020:4904217.10.1155/2020/4904217745030932908939
Search in Google Scholar Back to article
32. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Research. 2014;114:1867-1879.10.1161/CIRCRESAHA.114.302699407876724902971
Search in Google Scholar Back to article
33. Lahdentausta L, Leskelä J, Winkelmann A, et al. Serum MMP-9 diagnostics, prognostics, and activation in acute coronary syndrome and its recurrence. Journal of Cardiovascular Translational Research. 2018;11:210-220.10.1007/s12265-018-9789-x
Search in Google Scholar Back to article
34. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.10.1016/S0735-1097(98)00250-2
Search in Google Scholar Back to article
35. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American Heart Journal. 2001;141:211-217.10.1067/mhj.2001.11223811174334
Search in Google Scholar Back to article
36. Derosa G, D’Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart and Vessels. 2007;22:361-370.10.1007/s00380-007-0989-618043992
Search in Google Scholar Back to article
37. Dumitriu IE, Baruah P, Finlayson CJ, et al. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circulation Research. 2012;110:857-869.10.1161/CIRCRESAHA.111.26193322282196
Search in Google Scholar Back to article
38. Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nature Reviews Cardiology. 2020;17:387-401.10.1038/s41569-020-0352-5787221032203286
Search in Google Scholar Back to article
39. Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B. Infectious and coronary artery disease. ARYA Atheroscler. 2016;12:41-49.
Search in Google Scholar Back to article
40. Higuchi ML, Ramires JAF. Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Revista do Instituto de Medicina Tropical de São Paulo. 2002;44:217-224.10.1590/S0036-46652002000400007
Search in Google Scholar Back to article
41. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev. 2000;8:31-39.10.1097/00045415-200008010-00007
Search in Google Scholar Back to article
42. Pesonen E, El-Segaier M, Persson K, et al. Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Therapeutic Advances in Cardiovascular Disease. 2009;3:447-454.10.1177/175394470934559819773293
Search in Google Scholar Back to article
43. Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal Definition of Myocardial Infarction. Circulation. 2012;126:2020-2035.10.1161/CIR.0b013e31826e105822923432
Search in Google Scholar Back to article
44. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380:171-176.10.1056/NEJMra180813730625066
Search in Google Scholar Back to article
45. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-97910.1056/NEJM1997040333614019077376
Search in Google Scholar Back to article
46. Ridker P, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.10.1056/NEJM20000323342120210733371
Search in Google Scholar Back to article
47. Ridker PM. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813-1818.10.1161/01.CIR.103.13.181311282915
Search in Google Scholar Back to article
48. Ridker P, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.10.1056/NEJMoa02199312432042
Search in Google Scholar Back to article
49. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003;107:391-397.10.1161/01.CIR.0000055014.62083.05
Search in Google Scholar Back to article
50. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.10.1161/01.CIR.99.2.237
Search in Google Scholar Back to article
51. Coelho Graça D, Golaz O, Magnin J-L, et al. CRP-Based Cardiovascular Risk Assessment: New Conventional CRP Assay Fit for Purpose? The Journal of Applied Laboratory Medicine. 2018;2:952-959.
Search in Google Scholar Back to article
52. Danesh J, Wheeler JG, Hirschfield GM. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.10.1056/NEJMoa03280415070788
Search in Google Scholar Back to article
53. Wang TJ, Gona P, Larson MG. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639.10.1056/NEJMoa05537317182988
Search in Google Scholar Back to article
54. Blankenberg S, Zeller T, Saarela O. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation. 2010;121:2388-2397.10.1161/CIRCULATIONAHA.109.90141320497981
Search in Google Scholar Back to article
55. Seo WW, Kim H-L, Kim Y-J, et al. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography. Journal of Cardiology. 2016;68:222-22810.1016/j.jjcc.2015.09.010
Search in Google Scholar Back to article
56. Kubo T, Matsuo Y, Hayashi Y, et al. High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study. Coron Artery Dis. 2009;20:531-535.10.1097/MCA.0b013e328332a6b0
Search in Google Scholar Back to article
57. Sanchís J, Bodí V, Llácer A, et al. Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2004;57:382-387.10.1016/S0300-8932(04)77122-5
Search in Google Scholar Back to article
58. Inoue T, Kato T, Uchida T, et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol. 2005;46:239-245.10.1016/j.jacc.2005.04.02916022949
Search in Google Scholar Back to article
59. Mani P, Puri R, Schwartz GG, et al. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA Cardiol. 2019;4:314-320.10.1001/jamacardio.2019.0179648478530840024
Search in Google Scholar Back to article
60. Lucci C, Cosentino N, Genovese S, et al. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovasc Diabetol. 2020;19:183.10.1186/s12933-020-01157-7757682033081810
Search in Google Scholar Back to article
61. Suleiman M, Aronson D, Reisner SA, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med. 2003;115:695-701.10.1016/j.amjmed.2003.06.00814693321
Search in Google Scholar Back to article
62. Morariu M, Márton E, Mester A, et al. Association Between Acute Inflammatory Response and Infarct Size in Stemi Patients Undergoing Primary PCI. Journal Of Cardiovascular Emergencies. 2018;4:140-146.10.2478/jce-2018-0017
Search in Google Scholar Back to article
63. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38:1717-1727.
Search in Google Scholar Back to article
64. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2017;20:434-441.10.1111/1756-185X.1282026692475
Search in Google Scholar Back to article
65. Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a danish nationwide cohort study. Eur Heart J. 2012;33:2054-2064.10.1093/eurheartj/ehr28521840930
Search in Google Scholar Back to article
66. Efe TH, Cimen T, Ertem AG, et al. Atrial Electromechanical properties in inflammatory bowel disease. Echocardiography. 2016;33:1309-1316.10.1111/echo.1326127158773
Search in Google Scholar Back to article
67. Seferović PM, Ristić AD, Maksimović R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology. 2006;45:39-42.10.1093/rheumatology/kel31516980722
Search in Google Scholar Back to article
68. Korantzopoulos P, Letsas KP, Tse G, et al. Inflammation and atrial fibrillation: A comprehensive review. J Arrhythm. 2018;34:394-401.10.1002/joa3.12077611147730167010
Search in Google Scholar Back to article
69. Wu N, Xiang Y, Wu L, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis. Int J Cardiol. 2013;169:62-72.10.1016/j.ijcard.2013.08.07824095158
Search in Google Scholar Back to article
70. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.10176011739301
Search in Google Scholar Back to article
71. Rienstra M, Sun JX, Magnani JW, et al. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012;109:533-537.10.1016/j.amjcard.2011.09.049327011822100030
Search in Google Scholar Back to article
72. Weymann A, Ali-Hasan-Al-Saegh S, Sabashnikov A, et al. Prediction of new-onset and recurrent atrial fibrillation by complete blood count tests: a comprehensive systematic review with meta-analysis. Med Sci Monit Basic Res. 2017;23:179-222.10.12659/MSMBR.903320543953528496093
Search in Google Scholar Back to article
73. Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T. Usefulness of neutrophil/ lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res. 2015;46:199-206.10.1016/j.arcmed.2015.03.01125980945
Search in Google Scholar Back to article